Skip to main content

Endo Agrees To Pay $65M To Florida Over Opioid Crisis

Endo Agrees To Pay $65M To Florida Over Opioid Crisis

Endo Agrees To Pay $65M To Florida Over Opioid Crisis

Introduction

Endo International has agreed to pay up to $65 million to the state of Florida and local governments to resolve the claims against the company, alleging it of fueling the opioid epidemic.

Endo has struck many such settlements in recent months to resolve similar claims. It even includes a $63 million settlement with Texas that the company agreed on in December.

The company denied all the allegations by stating that they are not liable for the wrongdoing, and the move of paying the settlement amount is mainly concerned with addressing the global opioid epidemic.

The settlement amount from the company will be used by the state to conduct relevant awareness programs to prevent the future opioid crisis. It will even help the opioid abuse victims and their families to overcome the drug abuse.

The drugmakers, drug distributors and pharmacy chains face thousands of lawsuits over the drug abuse crisis, which has resulted in hundreds of thousands of overdose deaths over two decades.

The opioid crisis has been a major matter of concern throughout the U.S. for decades and the current $26 billion national opioid settlement, including three major drug distributors and drugmakers Johnson & Johnson, (J&J) is a big relief for the people affected and suffering from the opioids.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!